5-Methylfuran-2-boronicacid
Product Information
Molecular Formula
C5H7BO3
Molecular Weight
125.92
Description
5-Methylfuran-2-boronicacid is an exceptionally fascinating and innovative biomedicine chemical created to confront and combat a myriad of afflictions plaguing mankind. The groundbreaking properties exhibited by this compound exhibit a profound ability to thwart and impede the activity of specialized enzymes directly implicated in the unbridled advancement and proliferation of malignant tumors.
Synonyms
5-Methylfuran-2-boronic acid
IUPAC Name
(5-methylfuran-2-yl)boronic acid
SMILES
B(C1=CC=C(O1)C)(O)O
InChI
InChI=1S/C5H7BO3/c1-4-2-3-5(9-4)6(7)8/h2-3,7-8H,1H3
InChI Key
LMJIDBVSSSPRII-UHFFFAOYSA-N
Melting Point
72-77 °C (lit.)
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
126.0488242 g/mol
Monoisotopic Mass
126.0488242 g/mol
Topological Polar Surface Area
53.6Ų
Heavy Atom Count
9
Formal Charge
0
Complexity
96.2
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114149416-A | Dual-channel lipid drop fluorescent probe, preparation method and application thereof | 2021-11-18 |
| WO-2021224636-A1 | Antagonists of the adenosine a2a receptor | 2020-05-07 |
| CN-110922408-A | 3H- [1,2,3] triazolo [4,5-d ] pyrimidin-5-amine derivatives and uses thereof | 2019-12-12 |
| CN-110922408-B | 3H- [1,2,3] triazolo [4,5-d ] pyrimidin-5-amine derivatives and uses thereof | 2019-12-12 |
| CN-111116594-A | C-6 modified NanoLuc analogue and preparation method and application thereof | 2019-12-03 |
| CN-111116594-B | C-6 modified NanoLuc analogue and preparation method and application thereof | 2019-12-03 |
| WO-2021074281-A1 | Substituted azacyles as trmp8 modulators | 2019-10-17 |
| WO-2021007477-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 2019-07-11 |
| TW-202104147-A | Compound with 茀 frame and its manufacturing method | 2019-05-09 |
| WO-2020191261-A1 | Indazoles as lrrk2 inhibitors | 2019-03-21 |
